B Cells as a Therapeutic Target in Paediatric Rheumatic Disease.
Ontology highlight
ABSTRACT: B cells carry out a central role in the pathogenesis of autoimmune disease. In addition to the production of autoantibodies, B cells can contribute to disease development by presenting autoantigens to autoreactive T cells and by secreting pro-inflammatory cytokines and chemokines which leads to the amplification of the inflammatory response. Targeting both the antibody-dependent and antibody-independent function of B cells in adult rheumatic disease has led to the advent of B cell targeted therapies in clinical practice. To date, whether B cell depletion could also be utilized for the treatment of pediatric disease is relatively under explored. In this review, we will discuss the role of B cells in the pathogenesis of the pediatric rheumatic diseases Juvenile Idiopathic Arthritis (JIA), Ju
SUBMITTER: Wilkinson MGL
PROVIDER: S-EPMC6382733 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
ACCESS DATA